{"id":9073,"date":"2020-04-24T16:45:00","date_gmt":"2020-04-24T14:45:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/irlab-erbjuder-forhandsrostning-pa-arsstamman\/"},"modified":"2020-04-24T16:45:00","modified_gmt":"2020-04-24T14:45:00","slug":"irlab-erbjuder-forhandsrostning-pa-arsstamman","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-erbjuder-forhandsrostning-pa-arsstamman\/","title":{"rendered":"IRLAB erbjuder f\u00f6rhandsr\u00f6stning p\u00e5 \u00e5rsst\u00e4mman"},"content":{"rendered":"<p>[mfn_before_post]<\/p>\n<div class=\"mfn-preamble\"><strong>IRLAB:s styrelse har beslutat att aktie\u00e4garna ska f\u00e5 ytterligare tv\u00e5 m\u00f6jligheter att ut\u00f6va sin r\u00f6str\u00e4tt vid st\u00e4mman, f\u00f6rhandsr\u00f6stning eller genom fullmakt enligt den lag som tr\u00e4dde ikraft den 15 april 2020. Blanketter och instruktioner f\u00f6r detta \u00e5terfinns p\u00e5 bolagets webplats under menyn \u201dCorporate Governance\u201d.<\/strong><\/div>\n<p><span><span><span><span><span>Bolaget uppmuntrar sina aktie\u00e4gare att i st\u00f6rsta m\u00f6jliga utstr\u00e4ckning anv\u00e4nda m\u00f6jligheten att ut\u00f6va sin r\u00f6str\u00e4tt per post alternativt genom att st\u00e4lla ut fullmakt i syfte att minimera antalet deltagare som fysiskt n\u00e4rvarar vid st\u00e4mman och d\u00e4rmed minska risken f\u00f6r smittspridning av covid-19. <\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>F\u00f6r den som vill ut\u00f6va sin r\u00f6str\u00e4tt utan att deltaga fysiskt finns d\u00e4rmed nu tv\u00e5 alternativ ut\u00f6ver den normala m\u00f6jligheten att l\u00e4mna fullmakt till n\u00e5gon man utser sj\u00e4lv:<\/span><\/span><\/span><\/span><\/span><\/p>\n<ul>\n<li><span><span><span><strong><span><span>F\u00f6rhandsr\u00f6stning<\/span><\/span><\/strong><span><span>. Blankett och instruktioner f\u00f6r detta \u00e5terfinns p\u00e5 IRLAB:s webbplats.<\/span><\/span><\/span><\/span><\/span><\/li>\n<li><span><span><span><strong><span><span>L\u00e4mna fullmakt till Computershare<\/span><\/span><\/strong><span><span>. Blankett d\u00e4r instruktioner till Computershare ska l\u00e4mnas och instruktioner f\u00f6r detta \u00e5terfinns p\u00e5 IRLAB:s webbplats.<\/span><\/span><\/span><\/span><\/span><\/li>\n<\/ul>\n<p><span><span><span><strong><span><span>F\u00f6rhandsr\u00f6stning<\/span><\/span><\/strong><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>Vid f\u00f6rhandsr\u00f6stning ska en s\u00e4rskild blankett anv\u00e4ndas. Blanketten och ytterligare information om postr\u00f6stning finns tillg\u00e4ngligt p\u00e5 Bolagets webplats &#8211; <a href=\"https:\/\/www.irlab.se\/corporate-governance\/general-meeting\/annual-general-meeting-2020\/\" rel=\"nofollow\">www.bit.ly\/IRLAB-AGM-2020<\/a>. Blanketten kan \u00e4ven skickas med post till de aktie\u00e4gare som beg\u00e4r det och d\u00e4rvid uppger sin postadress. <\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>Om aktie\u00e4garen \u00e4r en juridisk person ska registreringsbevis eller annan beh\u00f6righetshandling bil\u00e4ggas blanketten i enlighet med vad som angetts i kallelsen till \u00e5rsst\u00e4mman. <\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>Aktie\u00e4garen f\u00e5r inte f\u00f6rse blanketten med s\u00e4rskilda instruktioner eller villkor. Om s\u00e5 sker \u00e4r r\u00f6sten ogiltig. Ytterligare anvisningar och villkor framg\u00e5r av blanketten.<\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>Den ifyllda blanketten i original m\u00e5ste vara Bolaget tillhanda senast m\u00e5ndagen den 4 maj 2020. Det ifyllda formul\u00e4ret i original ska skickas till f\u00f6ljande adress:<\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>IRLAB Therapeutics AB \u00c5rsst\u00e4mma 2020<\/span><\/span><\/span><\/span><\/span><br \/>\n<span><span><span><span><span>Computershare AB<\/span><\/span><\/span><\/span><\/span><br \/>\n<span><span><span><span><span>Box 5267<\/span><\/span><\/span><\/span><\/span><br \/>\n<span><span><span><span><span>102 46 Stockholm<\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>Ins\u00e4ndande av ifylld blankett g\u00e4ller \u00e4ven som anm\u00e4lan till \u00e5rsst\u00e4mman.<\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><strong><span><span>Fullmakt till Computershare<\/span><\/span><\/strong><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>Fullmakt till Computershare ska l\u00e4mnas p\u00e5 en s\u00e4rskild blankett som finns tillg\u00e4nglig p\u00e5 Bolagets webbplats &#8211; <a href=\"https:\/\/www.irlab.se\/corporate-governance\/general-meeting\/annual-general-meeting-2020\/\" rel=\"nofollow\">www.bit.ly\/IRLAB-AGM-2020<\/a>. <\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>Om aktie\u00e4garen \u00e4r en juridisk person ska registreringsbevis eller annan beh\u00f6righetshandling bil\u00e4ggas den undertecknade fullmakten i enlighet med vad som angetts i kallelsen till \u00e5rsst\u00e4mman. <\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>Aktie\u00e4garen f\u00e5r inte f\u00f6rse fullmakten med s\u00e4rskilda instruktioner eller villkor. Ytterligare anvisningar och villkor framg\u00e5r av blanketten.<\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>Den ifyllda fullmakten i original m\u00e5ste vara Computershare AB tillhanda senast m\u00e5ndagen den 4 maj 2020. Den undertecknade fullmakten i original, samt eventuella beh\u00f6righetshandlingar ska skickas till f\u00f6ljande adress:<\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>IRLAB Therapeutics AB \u00c5rsst\u00e4mma 2020<\/span><\/span><\/span><\/span><\/span><br \/>\n<span><span><span><span><span>Computershare AB<\/span><\/span><\/span><\/span><\/span><br \/>\n<span><span><span><span><span>Box 5267<\/span><\/span><\/span><\/span><\/span><br \/>\n<span><span><span><span><span>102 46 Stockholm<\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>Ins\u00e4ndande av undertecknad fullmakt till Computershare g\u00e4ller \u00e4ven som anm\u00e4lan till \u00e5rsst\u00e4mman.<\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><strong><span><span>Bakgrund<\/span><\/span><\/strong><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>F\u00f6rhandsr\u00f6stning och insamlande av fullmakter har m\u00f6jliggjorts genom antagandet av lagen (2020:198) om tillf\u00e4lliga undantag f\u00f6r att underl\u00e4tta genomf\u00f6randet av bolags- och f\u00f6reningsst\u00e4mmor. Lagen tr\u00e4dde ikraft den 15 april 2020. <\/span><\/span><\/span><\/span><\/span><\/p>\n<div class=\"mfn-footer\">\n<p><strong><span><span>F\u00f6r mer information<\/span><\/span><\/strong><\/p>\n<p><span><span>Viktor Siewertz, CFO\u00a0<br \/>\nTel: +46 727 10 70 70\u00a0<br \/>\nE-post: <a href=\"mailto:viktor.siewertz@irlab.se\" rel=\"nofollow\">viktor.siewertz@irlab.se<\/a><\/span><\/span><\/p>\n<p><span><span>Nicholas Waters, VD\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>\nTel: +46 730 75 77 01\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0\u00a0<br \/>\nE-post: <a href=\"mailto:nicholas.waters@irlab.se\" rel=\"nofollow\">nicholas.waters@irlab.se<\/a><\/span><\/span><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about\">\n<p><strong><span><span>Om IRLAB<\/span><\/span><\/strong><\/p>\n<p><span><span>IRLAB \u00e4r ett svenskt forsknings- och l\u00e4kemedelsutvecklingsbolag som fokuserar p\u00e5 att utveckla nya l\u00e4kemedel f\u00f6r behandling vid Parkinsons sjukdom. Bolagets l\u00e4ngst framskridna l\u00e4kemedelskandidater, mesdopetam (IRL790) och IRL752, vilka b\u00e5da genomg\u00e5tt Fas IIa-studier, \u00e4r avsedda f\u00f6r behandling av n\u00e5gra av de sv\u00e5raste symtomen relaterade till Parkinsons sjukdom: ofrivilliga r\u00f6relser (PD-LIDs), psykos (PD-P) och symtom som \u00e4r kopplade till kognitiv f\u00f6rs\u00e4mring s\u00e5som f\u00f6rs\u00e4mrad balans och \u00f6kad risk f\u00f6r fall (PD-Fall). Genom den propriet\u00e4ra forskningsplattformen ISP (Integrative Screening Process) uppt\u00e4cker och utvecklar IRLAB l\u00e4kemedelskandidater f\u00f6r sjukdomar relaterade till det centrala nervsystemet (CNS) d\u00e4r stora v\u00e4xande medicinska behov f\u00f6religger. F\u00f6rutom de kliniska kandidaterna har ISP-plattformen dessutom genererat flera CNS-program som nu \u00e4r i preklinisk fas. IRLAB:s Certified Adviser p\u00e5 Nasdaq First North Premier Growth Market \u00e4r FNCA Sweden AB, info@fnca.se, 08-528 00 399. Mer information p\u00e5 <a href=\"http:\/\/www.irlab.se\" rel=\"nofollow\">www.irlab.se<\/a>.<\/span><\/span><\/p>\n<\/div>\n<p>[mfn_after_post]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>IRLAB:s styrelse har beslutat att aktie\u00e4garna ska f\u00e5 ytterligare tv\u00e5 m\u00f6jligheter att ut\u00f6va sin r\u00f6str\u00e4tt vid st\u00e4mman, f\u00f6rhandsr\u00f6stning eller genom fullmakt enligt den lag som tr\u00e4dde ikraft den 15 april 2020. Blanketter och instruktioner f\u00f6r detta \u00e5terfinns p\u00e5 bolagets webplats under menyn &#8221;Corporate Governance&#8221;.<\/p>\n","protected":false},"template":"","class_list":["post-9073","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>IRLAB erbjuder f\u00f6rhandsr\u00f6stning p\u00e5 \u00e5rsst\u00e4mman - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/mfn_news\/irlab-erbjuder-forhandsrostning-pa-arsstamman\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB erbjuder f\u00f6rhandsr\u00f6stning p\u00e5 \u00e5rsst\u00e4mman - IRLAB\" \/>\n<meta property=\"og:description\" content=\"IRLAB:s styrelse har beslutat att aktie\u00e4garna ska f\u00e5 ytterligare tv\u00e5 m\u00f6jligheter att ut\u00f6va sin r\u00f6str\u00e4tt vid st\u00e4mman, f\u00f6rhandsr\u00f6stning eller genom fullmakt enligt den lag som tr\u00e4dde ikraft den 15 april 2020. Blanketter och instruktioner f\u00f6r detta \u00e5terfinns p\u00e5 bolagets webplats under menyn &quot;Corporate Governance&quot;.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/mfn_news\/irlab-erbjuder-forhandsrostning-pa-arsstamman\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-erbjuder-forhandsrostning-pa-arsstamman\/\",\"url\":\"https:\/\/irlab.se\/mfn_news\/irlab-erbjuder-forhandsrostning-pa-arsstamman\/\",\"name\":\"IRLAB erbjuder f\u00f6rhandsr\u00f6stning p\u00e5 \u00e5rsst\u00e4mman - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2020-04-24T14:45:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-erbjuder-forhandsrostning-pa-arsstamman\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/mfn_news\/irlab-erbjuder-forhandsrostning-pa-arsstamman\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-erbjuder-forhandsrostning-pa-arsstamman\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IRLAB erbjuder f\u00f6rhandsr\u00f6stning p\u00e5 \u00e5rsst\u00e4mman\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson&#039;s disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB erbjuder f\u00f6rhandsr\u00f6stning p\u00e5 \u00e5rsst\u00e4mman - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/mfn_news\/irlab-erbjuder-forhandsrostning-pa-arsstamman\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB erbjuder f\u00f6rhandsr\u00f6stning p\u00e5 \u00e5rsst\u00e4mman - IRLAB","og_description":"IRLAB:s styrelse har beslutat att aktie\u00e4garna ska f\u00e5 ytterligare tv\u00e5 m\u00f6jligheter att ut\u00f6va sin r\u00f6str\u00e4tt vid st\u00e4mman, f\u00f6rhandsr\u00f6stning eller genom fullmakt enligt den lag som tr\u00e4dde ikraft den 15 april 2020. Blanketter och instruktioner f\u00f6r detta \u00e5terfinns p\u00e5 bolagets webplats under menyn \"Corporate Governance\".","og_url":"https:\/\/irlab.se\/mfn_news\/irlab-erbjuder-forhandsrostning-pa-arsstamman\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"4 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/mfn_news\/irlab-erbjuder-forhandsrostning-pa-arsstamman\/","url":"https:\/\/irlab.se\/mfn_news\/irlab-erbjuder-forhandsrostning-pa-arsstamman\/","name":"IRLAB erbjuder f\u00f6rhandsr\u00f6stning p\u00e5 \u00e5rsst\u00e4mman - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2020-04-24T14:45:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/mfn_news\/irlab-erbjuder-forhandsrostning-pa-arsstamman\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/mfn_news\/irlab-erbjuder-forhandsrostning-pa-arsstamman\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/mfn_news\/irlab-erbjuder-forhandsrostning-pa-arsstamman\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"IRLAB erbjuder f\u00f6rhandsr\u00f6stning p\u00e5 \u00e5rsst\u00e4mman"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson&#039;s disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/9073","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=9073"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}